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The phosphorylation of thyroid transcription factor-1
(TTF-1), a homeodomain-containing transcription fac-
tor that is required for thyroid-specific expression of the
thyroglobulin and thyroperoxidase gene promoters, has
been studied. Phosphorylation occurs on a maximum of
seven serine residues that are distributed in three tryp-
tic peptides. Mutant derivatives of TTF-1, with alanine
residues replacing the serines in the phosphorylation
sites, have been constructed and used to assess the func-
tional relevance of TTF-1 phosphorylation. The DNA
binding activity of TTF-1 appears to be phosphoryla-
tion-independent, as indicated also by the performance
of TTF-1 purified from an overexpressing Escherichia
coli strain. Transcriptional activation by TTF-1 could
require phosphorylation only in specific cell types since
in a co-transfection assay in heterologous cells both
wild-type and mutant proteins show a similar transcrip-
tional activity.
The thyroid transcription factor-1 (TTF-1)1 is a homeodo-
main-containing transcription factor (1) that binds to the pro-
moters of thyroglobulin (Tg) and thyroperoxidase (TPO) genes,
whose expression is restricted to the thyroid follicular cells (2,
3). Transactivation studies demonstrated that TTF-1 is able to
activate transcription from co-transfected thyroglobulin and
thyroperoxidase promoters in non-thyroid cells, suggesting
that TTF-1 may play an important role in the transcriptional
activation of thyroid-specific genes during development (4, 5).
However, the presence of TTF-1 protein does not always corre-
late with active transcription of Tg and TPO genes, as TTF-1
has been demonstrated in tissues other than thyroid, where no
Tg and TPO mRNA could be detected. Furthermore, TTF-1
protein has been detected very early during thyroid develop-
ment, 5 days before the appearance of Tg and TPO mRNAs (6).
These data indicate that, in physiological conditions, TTF-1 is
not sufficient to activate transcription of thyroid-specific genes.
Such a notion is strongly supported by the observation that
transgenic mouse lines carrying a thyroglobulin promoter
fused to a chloramphenicol acetyltransferase gene express the
reporter only in thyroid, again indicating that TTF-1 present in
other tissues is unable to activate the Tg promoter (7). Inter-
estingly, the promoters of the surfactant protein B and A genes,
exclusively expressed in lung, have been demonstrated to de-
pend on TTF-1 for expression (8, 9). Taken together, these data
suggest that the activity of TTF-1 is differentially regulated.
Phosphorylation is perhaps the most frequent post-transla-
tional modification of those proteins whose activity is regulated
in response to changes in metabolic activity, environmental
conditions, and hormonal signals. Many transcription factors
are regulated by phosphorylation through several distinct
mechanisms (10–13) that can affect either their DNA binding
or their transcriptional activity. We have previously demon-
strated that, in the rat thyroid cell line FRTL-5, TTF-1 is
phosphorylated (14). Furthermore, in a Ha-ras-transformed
FRTL-5 cells TTF-1 has been demonstrated to be underphos-
phorylated and unable to activate transcription, suggesting
that phosphorylation could be an important mechanism in con-
trolling TTF-1 activity (14). It has also been proposed that
Ki-ras reduces the capacity of TTF-1 to bind to DNA via a
phosphorylation-dependent mechanism (15). We report in this
study the mapping of TTF-1 phosphorylation sites. TTF-1 mu-
tants unable to be phosphorylated show normal levels of DNA
binding and transcriptional activity in heterologous cells, sug-
gesting that phosphorylation of TTF-1 may have an important
role only in specific cell types.
MATERIALS AND METHODS
Plasmids Construction—Two primers (start) CCCGGGAAGCT-
TCTCCACTCAAGCCAATTAAGGCGG and (end) GCGCGCTCTA-
GAGAGCAGCGGGCGAATGGTGG were used to specifically amplify
the entire coding region of TTF-1 by polymerase chain reaction.HindIII
and XbaI sites, respectively, were included in these primers to facilitate
cloning. Specific serine codons were changed to alanine codons by po-
lymerase chain reaction as described previously, using primers contain-
ing the specific mutations, together with (start) and (end) primers.
The amplified products were cloned into the eukaryotic expression
vector Rc/CMV (Invitrogen). Finally, restriction fragments containing
the serine-alanine substitutions were excised and subcloned in CMV/
TTF-1, D14, or D26, described in De Felice et al. (5), to generate the
mutated constructs indicated in Figs. 2 and 4.
Cell Culture and Transfection Assay—The FRTL-5 cell line has been
previously described in detail (16). Briefly, FRTL-5 cells were grown in
Coon’s modified F-12 medium (Seromed) supplemented with 5% calf
serum (Life Technologies, Inc.) and six growth factors as described by
Ambesi-Impiombato and Coon (16). HeLa cells were grown in Dulbec-
co’s modified Eagle’s medium (DMEM) supplemented with 10% fetal
calf medium (Life Technologies, Inc.). For transient expression assays,
before the in vivo labeling, cells were plated at 8 3 105/100-mm diam-
eter tissue culture dish 1 day prior to transfection. Transfections were
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carried out by the calcium phosphate co-precipitation technique as
described elsewhere (4, 17). For transactivation experiments, cells were
plated at 4 3 105 cells/60-mm diameter tissue culture dish 5–8 h prior
to transfection. One microgram of a plasmid containing the luciferase
gene under the control of the cytomegalovirus enhancer/promoter was
used to monitor for transfection efficiency. Cell extracts were prepared
48 h after transfection, and the chloramphenicol acetyltransferase and
luciferase activities were determined as described previously (18, 19).
Biosynthetic Labeling and Immunodetection Techniques—Subconflu-
ent cultures of FRTL-5 or HeLa transfected cells were washed twice in
phosphate-free DMEM, then labeled in phosphate-free medium con-
taining 0.5 mCi of [32P]orthophosphate/ml for 3–4 h. Cells were then
lysed in a buffer containing 10 mM sodium phosphate (pH 7.4), 0.1 M
NaCl, 1% Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate, 2 mM
phenylmethylsulfonyl fluoride, 1 mg/ml pepstatin, 1 mg/ml leupeptin, 1
mg/ml aprotinin, 50 mM sodium fluoride, 10 mM sodium pyrophosphate,
and 5 mM sodium vanadate. Extracts were clarified by centrifugation,
an excess of TTF-1 antibody (6) was added, and immune complexes
were recovered on protein A-Sepharose beads (Pharmacia Biotech Inc.).
Blocking experiments were performed by preincubation of the anti-
peptides antibody with an excess of the corresponding synthetic anti-
genic peptide. Bound proteins were boiled in SDS-PAGE sample buffer
and resolved by electrophoresis in SDS-10% polyacrylamide gels (SDS-
10% PAGE). Labeling of HeLa cells was performed in a similar manner.
The cells were transfected with 15 mg of the expression vectors carrying
either wild-type TTF-1 or the deletion and point mutants, and after 36
h the cells were labeled and immunoprecipitated as above. For pulse-
chase experiments, FRTL-5 or transfected HeLa cells were labeled in
methionine-free DMEM containing 0.5 mCi of [35S]methionine for 1 h
(pulse), the medium was then removed, and the cells were incubated in
DMEM containing an 100-fold excess of nonradioactive methionine
(chase). For Western blot analysis, the samples were electroblotted onto
Immobilon membrane after SDS-PAGE, the blots were probed with the
same TTF-1 antibody used in immunoprecipitation, and the immuno-
complexes were identified by ECL (Amersham Corp.).
Phosphoamino Acids Analysis and Two-dimensional Phosphopeptide
Mapping—The immunoprecipitated proteins were resolved on SDS-
PAGE and subjected to a brief autoradiography, and the 32P-labeled
TTF-1 band was excised and eluted from the acrylamide. Phosphoamino
acid analysis and phosphopeptide mapping by two-dimensional sep-
aration on thin layer cellulose plates were carried out as described
elsewhere (20).
DNA-binding Assay—For gel shift assays, binding reactions were
carried out by incubating the proteins for 45 min in binding buffer (20
mM Tris, pH 7.6, 75 mM KCl, 100 mM NaCl, 3 mM dithiothreitol, 10%
glycerol, 1 mg/ml bovine serum albumin, 30 mg/ml poly(dIzdC) in a 20-ml
final volume) containing increasing concentrations of labeled oligonu-
cleotide C. Bound and free DNA were visualized by autoradiography,
and the data obtained from each titration were plotted in graphs. The
following equilibrium equation was fitted to the data by nonlinear
least-squares in order to calculate KD: [bound] 5 PozKD
21z[free]/(1 1
KD
21z[free]), where Po is the total concentration of TTF-1, KD is the
dissociation constant, and [bound] and [free] are the concentrations of
the bound and free oligonucleotide C probe, respectively.
In Vitro Kinase Assay—Purified TTF-1 from E. coli was used for in
vitro labeling with protein kinase C. Phosphorylation conditions were
the following. The reaction was carried out in 20 mM Hepes, pH 7.5, 10
mM MgCl2, 20 mM phospholipids (phosphatidylserine and diolein), 10
mCi of [g-32P]ATP, and 10 microunits of the kinase in each sample.
Protein kinase C from rat brain was purchased from Boehringer Mann-
heim. After labeling, the samples were resolved by SDS-PAGE.
RESULTS
TTF-1 Is Phosphorylated on Serine Residues in Three Tryptic
Peptides—FRTL-5 cells and HeLa cells, transiently transfected
with a TTF-1 expression vector, were metabolically labeled
with [32P]orthophosphate and TTF-1 was immunoprecipitated
from whole cells extracts by means of a specific anti-peptide
antibody. After electrophoresis and autoradiography, TTF-1
was detected as a band of the expected molecular mass (;43
kDa) (Fig. 1, Panel A, lanes 1 and 3). The specificity of the
immunoprecipitate was demonstrated by competition experi-
ments performed in the presence of an excess of the TTF-1
peptide used for immunization (lanes 2 and 4). When TTF-1
was revealed by Western blot in extracts from FRTL-5 and
transfected HeLa cells, a similar TTF-1 doublet was detected in
both cell lines (Fig. 1, Panel A, lanes 5 and 6). To determine the
amino acid residue(s) involved in phosphorylation, immunopre-
cipitated, 32P-labeled TTF-1 from both FRTL-5 and transfected
HeLa cells was acid-hydrolyzed and subjected to thin layer
electrophoresis/chromatography. In both cell lines, the result
indicated that TTF-1 is phosphorylated exclusively on serine
residues (Fig. 1, Panel B). Furthermore, the labeled TTF-1
band, eluted from the acrylamide gel after immunoprecipita-
tion, was extensively digested with trypsin, and the resulting
phosphopeptides were resolved by two-dimensional electro-
phoresis/chromatography (Fig. 1, Panel C). Three similar phos-
FIG. 1. TTF-1 is equally phosphorylated in FRTL-5 cells and
upon expression in HeLa cells. Panel A, immunoprecipitation of
TTF-1 from FRTL-5- and HeLa-transfected cells. Left, either thyroid
cells (FRTL-5) or HeLa cells transfected with a TTF-1 expression vector
were labeled with [32P]orthophosphate. Equal amounts of TTF-1 were
immunoprecipitated from the cell lysates with specific antibodies, the
protein was resolved by a 8% SDS-PAGE and detected by autoradiog-
raphy as described under “Materials and Methods.” Lanes 1 and 3 show
the phosphorylated TTF-1 from both cell types. The specificity of the
immunoprecipitation is demonstrated by competition with an excess of
the antigenic peptide (lanes 2 and 4). Lanes 5 and 6 show aWestern blot
of TTF-1 from FRTL-5 and transfected HeLa cells, respectively. Panel
B, phosphoamino acid analysis of TTF-1 immunoprecipitated from
FRTL-5 and transfected HeLa cells (left and right, respectively). Fol-
lowing detection by autoradiography (see Panel A) the bands corre-
sponding to 32P-TTF-1 from FRTL-5 and Hela cells were cut from the
gel, and the protein was processed as described under “Materials and
Methods.” The plates were exposed for autoradiography at 270 °C for
14 days with an intensifying screen. Panel C, tryptic maps of TTF-1
from FRTL-5- and HeLa-transfected cells (left and right, respectively).
32P-TTF-1 was purified by immunoprecipitation and electrophoresis,
then eluted from the gel and subjected to tryptic digestion as described
under “Materials and Methods.” Tryptic digests (;500 cpm/each) were
applied to thin layer cellulose plates, then resolved in the horizontal
dimension by electrophoresis at pH 8.9 (anode to the left) and the
vertical dimension by ascending chromatography as described under
“Materials and Methods.” The plates were exposed for autoradiography
at 270 °C for 10 days with an intensifying screen. The arrowmarks the
site of sample application.
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phopeptides could be detected (numbered 1, 2, and 3) whose
identity in the two cell lines used was confirmed by mixing
experiments (data not shown). These results validate the use of
HeLa cells as an heterologous expression system for the study
of TTF-1 phosphorylation.
Mapping of TTF-1 Phosphorylation Sites—In order to map
the phosphorylated serine residues in TTF-1, a series of dele-
tion and point mutation constructs were generated. Prelimi-
nary experiments using deletion mutants allowed us to localize
the phosphorylated residues in two regions, one near the amino
terminus of TTF-1 and the second on the carboxyl-terminal
side of the homeodomain (data not shown). We then focused on
these regions and mutagenized the codons for those serine
residues that, on the basis of their sequence context, were
candidate phosphorylation sites, to alanine codons (Fig. 2,
Panel A). The resulting mutant proteins were expressed in
HeLa cells, metabolically labeled with [32P]orthophosphate,
immunoprecipitated from whole cell extracts, and analyzed by
SDS-PAGE and autoradiography to examine their level of
phosphorylation (Fig. 2B, P-32). The presence of comparable
levels of TTF-1 in the different transfections was monitored by
Western blot (Fig. 2B, WB). A schematic drawing of the most
relevant mutants and their phosphorylation level is shown in
Fig. 2, Panels A and B, respectively. Deletion mutant D14, that
lacks all the region on the carboxyl-terminal side of TTF-1
homeodomain, is phosphorylated, but replacement of serines 4,
12, 18, and 23 with alanines (mutant DS40) results in a com-
plete loss of phosphorylation, indicating that one or more of
these serines are the substrate for protein kinases. Mutant
DS41 encodes for a TTF-1 mutated at the amino terminus as
DS40 and deleted of residues 221–294 at the carboxyl terminus
of the protein. Hence, DS41 phosphorylation must be located
among residues 295–372. Mutations of codons for serines 328
and 337 within this region results in a loss of phosphorylation,
thus allowing the identification of these two additional phos-
phorylation sites. Mutant S61 encodes a full-length TTF-1 pro-
tein containing Ser to Ala substitutions at residues 4, 12, 18,
23, 328, and 337. (Hence S61 cannot be phosphorylated at
neither of the two previously identified sites.) Since S61 is
phosphorylated, additional site(s) must exist among residues
221–294, in the region immediately downstream the homeodo-
main. Substitution of serine 255 with an alanine residue gen-
erates a full-length protein, named S80, completely unable to
incorporate inorganic 32P. A summary of all the mapped phos-
phoserines is shown in Fig. 2, Panel C. From this mutagenesis
study we can conclude that the identified 7 serines are the
major phosphorylation sites of TTF-1.
The Overall DNA Binding Activity of TTF-1 Is Phosphoryla-
tion-independent—Even though none of the mapped phospho-
rylation sites lies in the DNA-binding domain of TTF-1, we
asked whether the ability of TTF-1 to bind to its target se-
quence could depend upon phosphorylation. To test this hy-
pothesis, purified TTF-1 made in HeLa cells (Fig. 3, Panel A),
purified TTF-1 produced in E. coli (Fig. 3, Panel B), total
extracts of HeLa cells expressing either wild-type TTF-1 or
mutant S80 (Fig. 3, Panels C and D, respectively), and FRTL-5
nuclear extract (Fig. 3, Panel E) were compared for their affin-
ity toward the oligonucleotide C, containing a high affinity
TTF-1 binding site (17). The amount of TTF-1 from different
sources has been previously normalized by silver staining for
the purified proteins and by Western blot for the extracts (data
not shown). From the data shown in Fig. 3 it is evident that
none of the Ala to Ser replacements has an effect on TTF-1
binding activity (Fig. 3, Panels C and D). Furthermore, bacte-
rial TTF-1 shows the same affinity toward the C oligonucleo-
tide as the protein purified from HeLa cells or that present in
FRTL-5 nuclear extract (Fig. 3, Panels A, B, and E). Taken
together these experiments suggest that phosphorylation does
not directly influence the ability of TTF-1 to bind DNA.
Nonphosphorylated TTF-1 Can Activate Transcription in
HeLa Cells—We next approached the question of whether
phosphorylation modulates the ability of TTF-1 to activate
transcription. To this end, several expression vectors encoding
either wild-type or mutated TTF-1 and a reporter gene under
the control of the Tg promoter were co-transfected in HeLa
cells. As shown in Fig. 4, all TTF-1 mutants were able to
activate transcription as well as the wild-type protein. We
conclude that in heterologous HeLa cells transient transfection
assay TTF-1 does not require phosphorylation to activate
transcription.
TTF-1 Protein Exhibits a Slow Turnover in Both FRTL-5 and
HeLa Cells—The turnover of TTF-1 was studied in a pulse-
chase experiments. As shown in Fig. 5, the amount of 35S-
labeled TTF-1 decreased by 50% in about 14 h in FRTL-5 cells.
In addition, HeLa cells were transfected with an equal amount
of wild-type TTF-1 or mutant S80 which has all the seven
FIG. 2. Identification of phospho-
rylated serine residues in TTF-1.
Panel A, schematic representation of
TTF-1 mutants carrying the Ser/Ala sub-
stitutions. The constructs were generated
as described under “Materials and Meth-
ods.” Panel B, HeLa cells transfected with
expression vectors encoding the mutated
proteins were in vivo labeled with 32P,
and TTF-1 was purified by immunopre-
cipitation, then subjected to electropho-
resis, transferred to nitrocellulose, and
subjected to autoradiography (P-32) or
Western blot (WB) for quantification.
Lanes 1, 2, 3, 4, 5, and 6 are respectively
D14, DS40, DS41, DS63, S61, and S80.
Panel C, the amino acid sequence of
TTF-1 showing the major phosphoryla-
tion sites. The seven identified phospho-
serines are indicated in lower case letters.
The homeodomain is boxed.
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mapped serines substituted with alanines. The half-life of wild-
type TTF-1 in HeLa cells is also 14 h and no significant alter-
ation was observed with the S80 mutant (data not shown).
Protein Kinase C Phosphorylates TTF-1 in Vitro—In order to
determine whether any of the kinases for which a consensus
sequence is present among the phosphorylation sites of TTF-1
were indeed capable of phosphorylating this transcription fac-
tor, we performed in vitro phosphorylation experiments.
Among several protein kinases tested, only protein kinase C
was able to phosphorylate TTF-1 in vitro (Fig. 6) (data not
shown). These data suggest that TTF-1 could be a target for a
specific cell signaling pathway.
DISCUSSION
In this study, we have identified the phosphorylation sites of
TTF-1, a transcription factor implicated in the activation of
both thyroid- (21, 22) and lung-specific (8, 9) transcriptional
units. TTF-1 is phosphorylated exclusively on serine residues
in three different tryptic peptides. The number of phosphoryl-
ated serines may range from a minimum of 5 to a maximum of
7 sites, given the uncertainty on the cluster of serines at the
amino terminus. Fine mapping of the sites has been obtained in
HeLa cells, by measuring the incorporation of labeled phos-
phate into TTF-1 mutants missing putative phosphorylation
sites. Interestingly, no sites for protein kinase A are observed,
even though an important role has been proposed for phospho-
rylation of TTF-1 by this protein kinase (15). The sites that we
have identified show homology to CKII (Ser-18), protein kinase
C (Ser-4, -23, and -255), or microtubule-associated protein ki-
nase (Ser-328 and -337) phosphorylation sites. These protein
kinases are components of signal transduction pathways that
have been shown to control thyroid function and to be activated
in thyroid cells in response to a variety of stimuli (23). In our in
vitro experiments only protein kinase C was able to phospho-
rylate TTF-1. This result is of interest since activation of pro-
tein kinase C has been suggested to inhibit thyroid cell differ-
entiation (24–30). Furthermore, activation of protein kinase C
has been implicated in TSH stimulation of thyroid cell growth
(31, 32). Since TTF-1 has been implicated both in the expres-
sion of thyroid differentiated function (21) and in the control of
thyroid cell growth (33), it is an attractive hypothesis that some
of these functions could be controlled via phosphorylation of
TTF-1 by protein kinase C. The data presented in this study do
not, at present, support this hypothesis, since we could not
demonstrate any alteration in TTF-1 activity as a consequence
of the lack of phosphorylation. However, we cannot rule out the
possibility that we were unable to provide evidence for the
relevance of phosphorylation in TTF-1 because of the transient
transfection assay in heterologous cells that we used. The reg-
ulation of TTF-1 through phosphorylation may impinge on
thyroid-specific mechanisms which do not operate in HeLa cells
such as, for example, phosphorylation-dependent interaction
(34) with specific co-activators. Future experiments should aim
at studying the phosphorylation mutants in thyroid cells. More
conclusive are our studies on the role of phosphorylation in the
DNA binding activity of TTF-1. Phosphorylation has been in-
dicated as a critical step for the binding of TTF-1 to its target
sequence on the Tg promoter (15, 35) as well as on the TSHr
one (36). Moreover, TTF-1 binding was shown to be abrogated
when nuclear extracts were incubated with acid phosphatases.
Treatment of extracts with protein kinase A (15) was able to
restore TTF-1 DNA binding activity, leading to the conclusion
that TTF-1 is directly modified by protein kinase A and binds to
the Tg promoter only if phosphorylated (35). In contrast, our
results clearly show that phosphorylation does not play an
important role in the overall TTF-1 DNA binding activity. This
conclusion is based on the comparable affinities toward a dou-
ble-stranded oligonucleotide containing a well characterized
TTF-1 binding site (oligonucleotide C) (17) of wild-type TTF-1,
purified from either bacteria or animal cells, and of the S80
mutant, that contains less that 0.1 phosphorus atom/molecule.
We cannot exclude that ancillary proteins, which are protein
kinase A substrates, could either help or interfere with TTF-1
binding (15), depending on the physiological conditions. In ad-
dition, we have recently discovered that TTF-1 DNA binding
activity can be easily lost during extract preparation and can be
readily recovered by exposure to reducing agents (37). It is also
conceivable that the exquisite sensitivity of TTF-1 to oxidation
could interfere with the interpretation of in vitro treatments
with phosphatases and kinases.
Previous data from our laboratory have demonstrated that
TTF-1 is inactive in Ha-ras-transformed cells, although it is
present and capable of binding to DNA (14). In this cell line, we
have observed a reduced phosphorylation of TTF-1 (14), and we
proposed that this could be the cause for the inactivity of TTF-1
in transformed cells. In this respect, it is interesting to note
that ras activation has been reported to affect the stimulation
FIG. 3. Phosphorylation does not affect the affinity of TTF-1
for the oligonucleotide C. Purified HeTTF-1 (0.5 ng) (Panel A),
purified bTTF-1 (2 ng) (Panel B), HeLa-transfected total extracts (about
3 mg) containing 0.5 ng of wild-type TTF-1 (Panel C), or 0.5 ng of mutant
S80 (Panel D), or FRTL-5 nuclear extracts (about 2 mg) containing 0.5
ng of TTF-1 (Panel E) (the concentrations of TTF-1 in the extracts were
determined by Western blotting analysis) were incubated for 45 min in
binding buffer containing increasing concentrations of labeled oligonu-
cleotide C. Bound and free DNA were visualized by autoradiography,
and the data obtained from each titration were plotted in the graphs
A–E. HeTTF-1:TTF-1 was purified from overexpressing HeLa cells (37)
and bTTF-1:TTF-1 was purified from overexpressing E. coli cells.
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of protein kinase C in Xenopus oocytes (38) and in PC12 cells
(39). It is also noteworthy the role of Ras proteins in signal
transduction pathways initiated in membrane receptors (insu-
lin-like growth factor-I, insulin, and epidermal growth factor)
and involving microtubule-activating protein kinases. These
alterations in protein kinases activities can be somehow affect-
ing TTF-1, either by a direct or an indirect mechanism involv-
ing other kinases and/or phosphatases. The characterization of
the phosphorylation sites in TTF-1 may be instrumental for the
elucidation of the mechanisms leading to the interference be-
tween transformation and differentiation in thyroid cells.
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